Biotechnology & Medical Research

BioLegend acquires Antibody Products business unit from Covance Inc

Covance Inc:Acquires shares of Covance Antibody Services Inc., business unit of Covance, located in Dedham, Massachusetts, on Aug. 29.Covance Antibody business unit develops and manufactures antibodies and research reagents for Neuroscience, Immunopathology, Cell Biology, Epitope Tags, and...

11:00am EDT

ACADIA Pharmaceuticals Inc receives FDA breakthrough therapy designation for NUPLAZID (Pimavanserin) for Parkinson's Disease Psychosis

ACADIA Pharmaceuticals Inc:Announced that U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID (pimavanserin) for treatment of Parkinson's disease psychosis.Says NUPLAZID is selective serotonin inverse agonist and, if approved, will establish new and...

9:00am EDT

Capstone Therapeutics announces Phase 1a results for AEM-28 showing safety and biomarker efficacy signals

Capstone Therapeutics Corp:Says the company and its joint venture affiliate,LipimetiX Development, LLC (JV),announced the completion of dosing and patient follow-up for its investigational AEM-28 (Apo E mimetic peptide) Phase 1a human clinical trial in cholesterol and lipid reduction.Medical Safety...

9:00am EDT

Aurinia Pharmaceuticals Inc to begin trading on NASDAQ Global Market

Aurinia Pharmaceuticals Inc:Announced that company has received approval by NASDAQ Listing Qualifications Department to list its common shares on NASDAQ Global Market.Trading commenced from Sept. 2.Company's shares will continue to trade on Toronto Stock Exchange (TSX) under trading symbol AUP.

8:00am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.